Echinococcus multilocularis: Difference between revisions

From IDWiki
Echinococcus multilocularis
Line 23: Line 23:
 
** Rare in North America
 
** Rare in North America
 
* Within Canada:
 
* Within Canada:
  +
** Associated with arctic foxes and wolves
 
** Alberta has highest number of cases, with 19 cases from 2013 to 2021
 
** Alberta has highest number of cases, with 19 cases from 2013 to 2021
 
** 0 to 3 case reports in other provinces
 
** 0 to 3 case reports in other provinces

Revision as of 12:16, 4 May 2022


Background

Microbiology

  • Cestode in the Echinococcus family
  • Disease is caused by the larval form

Life Cycle

  • Definitive hosts are canid carnivorous animals, including urban coyotes
  • Eggs contaminate the environment, including produce
    • They are infective after a few days, and are viable for up to 16 months at 4ΒΊC
  • Intermediate hosts (metacestode) are rodents, possibly pigs, and and incidentally humans
  • Intermediate host is eaten by the definitive host, completing the life cycle

Epidemiology

  • Estimated 18,000 cases annually
  • Worldwide in the northern hemisphere
    • Most cases in China (90%), followed by Japan and Russia
    • Rare in North America
  • Within Canada:
    • Associated with arctic foxes and wolves
    • Alberta has highest number of cases, with 19 cases from 2013 to 2021
    • 0 to 3 case reports in other provinces

Clinical Manifestations

  • Causes alveolar echinococcosis
  • Incubation period 5 to 15 years
  • Vague abdominal pain may precede diagnosis by years
  • Presents as a metastatic malignancy of unknown primary, mot commonly with malaise, weight loss, and right upper quadrant discomfort
  • Can cause cholestatic jaundrice, cholangitis, portal hypertension, and Budd-Chiari syndrome

Diagnosis

  • Combination of radiologic and serologic investigations
  • A single negative serologic test does not rule out infection
  • May be confirmed by biopsy

Case Definition (Alberta)

  • Typical organ lesion detected by imaging with US or CT
  • AND histopathology compatible with alveolar echinococcosis
  • AND
    • Detection of E. multilocularis by serology
    • OR detection of E. multilocularis by molecular diagnostic methods

Management

  • Main treatment is surgical resection followed by at least 2 years of antihelminthic therapy (e.g. albendazole)
  • Poor prognosis, with 90% 10-year mortality if untreated